View in EDS

Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.

Saved in:
Bibliographic Details
Title: Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.
Authors: Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, USA. usmanis@mskcc.org., Facon T; University of Lille, CHU de Lille, Service des Maladies du Sang, Lille, France., Hungria V; Clínica Médica São Germano, São Paulo, Brazil., Bahlis NJ; Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada., Venner CP; Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.; BC Cancer-Vancouver Centre, University of British Columbia, Vancouver, British Columbia, Canada., Braunstein M; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Pour L; University Hospital Brno, Brno, Czech Republic., Martí JM; Hospital Universitario Mútua de Terrassa, Terrassa, Spain., Basu S; Royal Wolverhampton NHS Trust and University of Wolverhampton, CRN West Midlands, National Institute for Health and Care Research, Wolverhampton, UK., Cohen YC; Department of Hematology, Tel Aviv Sourasky (Ichilov) Medical Center, Tel Aviv, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Matsumoto M; Department of Hematology, National Hospital Organization Shibukawa Medical Center, Gunma, Japan., Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France., Grosicki S; Department of Hematology and Cancer Prevention, School of Public Health, Medical University of Silesia, Katowice, Poland., Legiec W; Department of Hematology and Bone Marrow Transplantation, St. John of Dukla Oncology Center of Lublin Land, Lublin, Poland., Beksac M; Istinye University, Ankara Liv Hospital, Ankara, Turkey., Maiolino A; Instituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, Brazil.; Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Takamatsu H; Department of Hematology, Kanazawa University Hospital, Kanazawa University, Kanazawa, Japan., Perrot A; CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d'Hématologie, Toulouse, France., Turgut M; Department of Hematology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey., Ahmadi T; Genmab US, Inc., Plainsboro, NJ, USA., Liu W; Johnson & Johnson, Shanghai, China., Wang J; Johnson & Johnson, Spring House, PA, USA., Chastain K; Johnson & Johnson, Raritan, NJ, USA., Vermeulen J; Johnson & Johnson, Leiden, The Netherlands., Krevvata M; Johnson & Johnson, Spring House, PA, USA., Lopez-Masi L; Johnson & Johnson, Raritan, NJ, USA., Carey J; Johnson & Johnson, Spring House, PA, USA., Rowe M; Johnson & Johnson, High Wycombe, UK., Carson R; Johnson & Johnson, Spring House, PA, USA., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Source: Nature medicine [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1366.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39948407
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Usmani+SZ%22">Usmani SZ</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA. usmanis@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Facon+T%22">Facon T</searchLink>; University of Lille, CHU de Lille, Service des Maladies du Sang, Lille, France.<br /><searchLink fieldCode="AU" term="%22Hungria+V%22">Hungria V</searchLink>; Clínica Médica São Germano, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Bahlis+NJ%22">Bahlis NJ</searchLink>; Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Venner+CP%22">Venner CP</searchLink>; Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.; BC Cancer-Vancouver Centre, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Braunstein+M%22">Braunstein M</searchLink>; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pour+L%22">Pour L</searchLink>; University Hospital Brno, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Martí+JM%22">Martí JM</searchLink>; Hospital Universitario Mútua de Terrassa, Terrassa, Spain.<br /><searchLink fieldCode="AU" term="%22Basu+S%22">Basu S</searchLink>; Royal Wolverhampton NHS Trust and University of Wolverhampton, CRN West Midlands, National Institute for Health and Care Research, Wolverhampton, UK.<br /><searchLink fieldCode="AU" term="%22Cohen+YC%22">Cohen YC</searchLink>; Department of Hematology, Tel Aviv Sourasky (Ichilov) Medical Center, Tel Aviv, Israel.; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Matsumoto+M%22">Matsumoto M</searchLink>; Department of Hematology, National Hospital Organization Shibukawa Medical Center, Gunma, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+K%22">Suzuki K</searchLink>; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hulin+C%22">Hulin C</searchLink>; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France.<br /><searchLink fieldCode="AU" term="%22Grosicki+S%22">Grosicki S</searchLink>; Department of Hematology and Cancer Prevention, School of Public Health, Medical University of Silesia, Katowice, Poland.<br /><searchLink fieldCode="AU" term="%22Legiec+W%22">Legiec W</searchLink>; Department of Hematology and Bone Marrow Transplantation, St. John of Dukla Oncology Center of Lublin Land, Lublin, Poland.<br /><searchLink fieldCode="AU" term="%22Beksac+M%22">Beksac M</searchLink>; Istinye University, Ankara Liv Hospital, Ankara, Turkey.<br /><searchLink fieldCode="AU" term="%22Maiolino+A%22">Maiolino A</searchLink>; Instituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, Brazil.; Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Takamatsu+H%22">Takamatsu H</searchLink>; Department of Hematology, Kanazawa University Hospital, Kanazawa University, Kanazawa, Japan.<br /><searchLink fieldCode="AU" term="%22Perrot+A%22">Perrot A</searchLink>; CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d'Hématologie, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Turgut+M%22">Turgut M</searchLink>; Department of Hematology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey.<br /><searchLink fieldCode="AU" term="%22Ahmadi+T%22">Ahmadi T</searchLink>; Genmab US, Inc., Plainsboro, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; Johnson & Johnson, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Chastain+K%22">Chastain K</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Vermeulen+J%22">Vermeulen J</searchLink>; Johnson & Johnson, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Krevvata+M%22">Krevvata M</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lopez-Masi+L%22">Lopez-Masi L</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Carey+J%22">Carey J</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rowe+M%22">Rowe M</searchLink>; Johnson & Johnson, High Wycombe, UK.<br /><searchLink fieldCode="AU" term="%22Carson+R%22">Carson R</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zweegman+S%22">Zweegman S</searchLink>; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1366.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39948407
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-025-03581-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1366
    Titles:
      – TitleFull: Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Usmani SZ
      – PersonEntity:
          Name:
            NameFull: Facon T
      – PersonEntity:
          Name:
            NameFull: Hungria V
      – PersonEntity:
          Name:
            NameFull: Bahlis NJ
      – PersonEntity:
          Name:
            NameFull: Venner CP
      – PersonEntity:
          Name:
            NameFull: Braunstein M
      – PersonEntity:
          Name:
            NameFull: Pour L
      – PersonEntity:
          Name:
            NameFull: Martí JM
      – PersonEntity:
          Name:
            NameFull: Basu S
      – PersonEntity:
          Name:
            NameFull: Cohen YC
      – PersonEntity:
          Name:
            NameFull: Matsumoto M
      – PersonEntity:
          Name:
            NameFull: Suzuki K
      – PersonEntity:
          Name:
            NameFull: Hulin C
      – PersonEntity:
          Name:
            NameFull: Grosicki S
      – PersonEntity:
          Name:
            NameFull: Legiec W
      – PersonEntity:
          Name:
            NameFull: Beksac M
      – PersonEntity:
          Name:
            NameFull: Maiolino A
      – PersonEntity:
          Name:
            NameFull: Takamatsu H
      – PersonEntity:
          Name:
            NameFull: Perrot A
      – PersonEntity:
          Name:
            NameFull: Turgut M
      – PersonEntity:
          Name:
            NameFull: Ahmadi T
      – PersonEntity:
          Name:
            NameFull: Liu W
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Chastain K
      – PersonEntity:
          Name:
            NameFull: Vermeulen J
      – PersonEntity:
          Name:
            NameFull: Krevvata M
      – PersonEntity:
          Name:
            NameFull: Lopez-Masi L
      – PersonEntity:
          Name:
            NameFull: Carey J
      – PersonEntity:
          Name:
            NameFull: Rowe M
      – PersonEntity:
          Name:
            NameFull: Carson R
      – PersonEntity:
          Name:
            NameFull: Zweegman S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2025 Apr
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1